Affiliated Companies and Co-operations

Activities

Activities per year 1998 2017 2018 2019 2020 2021 2022 2023 2024

• 867 Talk at conference or symposium
• 299 Talk at workshop, seminar or course
• 97 Invited talk
• 92 Conference or symposium (Participation in/Organisation of)
• 351 More
  • 62 Workshop, seminar or course (Participation in/Organisation of)
  • 59 Invited talk at conference or symposium
  • 49 Poster presentation
  • 37 Peer review of manuscripts
  • 30 Membership of research network or expert group
  • 29 Public lecture or debate
  • 10 Festival or exhibition (Participation in/Organisation of)
  • 10 Editorial activity
  • 9 External supervision
  • 9 Schools engagement
  • 9 Research at external institution
  • 6 Consultancy
  • 6 External examination
  • 4 Membership in Jury
  • 3 Competition (Participation in/Organisation of)
  • 3 External supervision and examination
  • 3 Hosting a visitor
  • 3 Membership of external institution
  • 2 Membership of examination board
  • 2 Membership of review or evaluation panel
  • 2 Public event
  • 2 Participation in TV / radio programme or webbased media
  • 1 Public lecture or debate (Participation in/Organisation of)
  • 1 Membership in Programm Committee

Activities per year

Search results

• Von der Handy-Signatur zur ID Austria und digitalen Ausweisen

  Arne Tauber (Speaker)

  12 May 2022

  Activity: Talk or presentation › Invited talk › Science to public

• Partnermeeting mit Freunden der hbf

  Gerhard Schickhofer (Speaker)

  18 Nov 2022

  Activity: Talk or presentation › Invited talk › Science to public

• 25 Years After the Ro5 – Trends in the Chemical Space and Drug Delivery

  Sven Stegemann (Speaker)

  27 Jun 2022 → 29 Jun 2022

  Activity: Talk or presentation › Invited talk › Science to science

• ld and multimorbid – from patient involvement to better drug products

  Sven Stegemann (Speaker)

  2 Jun 2022

  Activity: Talk or presentation › Invited talk › Science to science

• Brandversuche von batterieelektrischen Fahrzeugen

  Patrik Fößleitner (Speaker)

  28 Jan 2022

  Activity: Talk or presentation › Invited talk › Science to public

• Acceptability” – A marketing issue?

  Sven Stegemann (Speaker)

  22 Jun 2022

  Activity: Talk or presentation › Invited talk › Science to science

• Design of CLT according to 3rd Draft of prEN 1995-1-2

  Manfred Augustin (Speaker) & Alexandra Thiel (Contributor)

  9 Apr 2021

  Activity: Talk or presentation › Invited talk › Science to science

• Differentiation-based State Estimation in LTI Systems with unknown Inputs

  Helmut Niederwieser (Speaker), Markus Tranninger (Contributor), Richard Seeber (Contributor) & Markus Reichhartinger (Contributor)

  29 Sept 2021

  Activity: Talk or presentation › Invited talk › Science to science

• Brandversuche von batterieelektrischen Fahrzeugen

  Patrik Fößleitner (Speaker)

  6 May 2021

  Activity: Talk or presentation › Invited talk › Science to public

• Social Entrepreneurship Lab

  Martin Glinik (Speaker)

  17 Dec 2021

  Activity: Talk or presentation › Invited talk › Science to science

• Meeting the Formulation and Delivery Needs of Special Patient Populations: Focus on Pediatrics and Geriatrics

  Sven Stegemann (Speaker)

  28 Oct 2021

  Activity: Talk or presentation › Invited talk › Science to science

• Brandversuche von batterieelektrischen Fahrzeugen

  Patrik Fößleitner (Speaker)

  11 Oct 2021

  Activity: Talk or presentation › Invited talk › Science to public

• The very old and drug delivery - friend or foe

  Sven Stegemann (Speaker)

  29 Sept 2020

  Activity: Talk or presentation › Invited talk › Science to science

• Lecturing Entrepreneurship at an Academic Start-up Accelerator

  Martin Glinik (Speaker)

  9 Mar 2020

  Activity: Talk or presentation › Invited talk › Science to science

• Wasserstoff-Verbrennungsmotor - Entwicklungsgeschichte und aktueller Stand

  Peter Grabner (Speaker) & Klaus Maria Schaffer (Speaker)

  4 Mar 2020

  Activity: Talk or presentation › Invited talk › Science to public

• Drug Research and Development for Adults Across the Older Age Span

  Sven Stegemann (Speaker)

  6 Aug 2020

  Activity: Talk or presentation › Invited talk › Science to science

• Drug Research and Development for Adults Across the Older Age Span

  Sven Stegemann (Speaker)

  23 Oct 2020

  Activity: Talk or presentation › Invited talk › Science to science

• In progress, Unique Identifiers on Dosage Forms to Prevent Counterfeits and Falsified Medicines

  Sven Stegemann (Speaker)

  11 Mar 2020

  Activity: Talk or presentation › Invited talk › Science to science

• The pandemic – drawback or advance in patient centric drug development for older adults

  Sven Stegemann (Speaker)

  23 Oct 2020

  Activity: Talk or presentation › Invited talk › Science to science

• Austrian mobile eID/signature

  Herbert Leitold (Speaker)

  29 Oct 2019

  Activity: Talk or presentation › Invited talk › Science to science

• Lecturing Entrepreneurship at an Academic Start-up Accelerator

  Martin Glinik (Speaker)

  28 Oct 2019

  Activity: Talk or presentation › Invited talk › Science to science

• Engineering particles to deliver high dosed and sensitive drugs to the lung using standard inhaler systems

  Sven Stegemann (Speaker)

  23 May 2019

  Activity: Talk or presentation › Invited talk › Science to science

• The demographic & multimorbidity (r)evolution – an opportunity for pharmaceutical industry

  Sven Stegemann (Speaker)

  12 Sept 2019

  Activity: Talk or presentation › Invited talk › Science to science

• Towards flavors and fragrances with enzymes and microbes

  Margit Winkler (Speaker)

  15 Nov 2019

  Activity: Talk or presentation › Invited talk › Science to science

• Einführung Brettsperrholz (BSP)

  Reinhard Brandner (Speaker) & Alexandra Thiel (Contributor)

  25 Jul 2019

  Activity: Talk or presentation › Invited talk › Science to science

• Mit Enzymen und Mikroben zu Bioflavours

  Margit Winkler (Speaker)

  4 Jun 2019

  Activity: Talk or presentation › Invited talk › Science to science

• Patient Centric Medicine (PaCeMe) initiative: Building a “Road-Map” to patient centric product design

  Sven Stegemann (Speaker)

  16 Apr 2019

  Activity: Talk or presentation › Invited talk › Science to science

• Fire Consequences of Electric Vehicles

  Patrik Fößleitner (Speaker) & Peter-Johann Sturm (Contributor)

  24 Oct 2019

  Activity: Talk or presentation › Invited talk › Science to public

• Selecting and specifying capsule to achieve targeted fine particle release

  Sven Stegemann (Speaker)

  20 Sept 2018

  Activity: Talk or presentation › Invited talk › Science to science

• Medicine development for the older and clinically complex patients – Closing the gaps to patient centric product design

  Sven Stegemann (Speaker)

  25 May 2018

  Activity: Talk or presentation › Invited talk › Science to science

• Closing the gaps in medicine development for the older population – Outcomes and actions from an APV workshop

  Sven Stegemann (Speaker)

  21 Mar 2018

  Activity: Talk or presentation › Invited talk › Science to science

• Mikrostruktur von 3D gedruckten Materialien

  Hartmuth Schröttner (Speaker), Ferdinand Hofer (Speaker) & Mihaela Albu (Speaker)

  24 May 2018

  Activity: Talk or presentation › Invited talk › Science to public

• Discovery, characterization and application of carboxylic acid reductases

  Margit Winkler (Speaker)

  12 Nov 2018

  Activity: Talk or presentation › Invited talk › Science to science

• Multimorbidität und hohes Alter – eine neue pharmazeutische und galenische Herausforderung

  Sven Stegemann (Speaker)

  23 Oct 2018

  Activity: Talk or presentation › Invited talk › Science to science

• Regelung verfahrens- und energietechnischer Anlagen. Zukünftige Möglichkeiten durch zunehmende Digitalisierung.

  Markus Gölles (Speaker)

  10 Jul 2018

  Activity: Talk or presentation › Invited talk › Science to science

• Wearable diagnostics as an opportunity for physicians, patient, industry and healthcare providers

  Sven Stegemann (Speaker)

  12 Nov 2017

  Activity: Talk or presentation › Invited talk › Science to science

• Entscheidungssicherheit mit Data-Driven Design

  Christoph Schinko (Speaker)

  19 Jun 2017

  Activity: Talk or presentation › Invited talk › Science to public

• Disruptive demographics – Longevity as a personal and societal opportunity

  Sven Stegemann (Speaker)

  9 Nov 2017

  Activity: Talk or presentation › Invited talk › Science to science

• Hard capsules as a dosage form to close the gap between efficacy and effectiveness

  Sven Stegemann (Speaker)

  19 Jun 2017

  Activity: Talk or presentation › Invited talk › Science to science

• Enzymatic Reactions for Industrial Biotechnology

  Margit Winkler (Speaker)

  8 Dec 2017

  Activity: Talk or presentation › Invited talk › Science to science

• Oleate hydratases - structure function relationships and application

  Harald Pichler (Speaker)

  1 Oct 2016

  Activity: Talk or presentation › Invited talk › Science to science

• Formulation for older people and synergies with pediatrics

  Sven Stegemann (Speaker)

  8 Apr 2016

  Activity: Talk or presentation › Invited talk › Science to science

• Power of Microbes in industry and environment 2016

  Harald Pichler (Speaker)

  1 Oct 2016

  Activity: Talk or presentation › Invited talk › Science to science

• Investigating and selecting the optimal capsule based on capsule-formulation and device-capsule interaction to improve product performance.

  Sven Stegemann (Speaker)

  1 Mar 2016

  Activity: Talk or presentation › Invited talk › Science to science

• Molecular Biotechnology-From the Origins to new Horizons

  Harald Pichler (Speaker)

  14 Apr 2016

  Activity: Talk or presentation › Invited talk › Science to science

• Hard gelatin capsule formulation development based on QbD

  Sven Stegemann (Speaker)

  27 Jan 2016

  Activity: Talk or presentation › Invited talk › Science to science

• eID Best Practice EU

  Herbert Leitold (Speaker)

  5 Dec 2016

  Activity: Talk or presentation › Invited talk › Science to public

• From patient research to patient centric product design: Focusing on the geriatric and pediatric population

  Sven Stegemann (Speaker)

  27 May 2016

  Activity: Talk or presentation › Invited talk › Science to science

• Opportunities for generic developers

  Sven Stegemann (Speaker)

  27 Jan 2016

  Activity: Talk or presentation › Invited talk › Science to science

• From ‘me-too’ to ‘added value me too’ to ‘enhanced therapeutic’ (“supergeneric”): A way to create competitive advantages in the generic business

  Sven Stegemann (Speaker)

  22 Apr 2016

  Activity: Talk or presentation › Invited talk › Science to science